FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental NDA for VAGIFEM (estradiol) by Novo Nordisk, updating its label as part of a supplemental application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause

Drugs mentioned

• Vagifem (Estradiol)

Snippet

SUPPL AP for VAGIFEM (ESTRADIOL)